norm: omerosNAICS 325412 · USLEI 549300CJWLXX2MXVVV71 · CIK 0001285819Max severity: Low

Canonical registry

OMEROS CORPORATION

ent_019e5cc19bf45b4da1b8937933db1688

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: OMEROS CORPORATION
Normalized: omeros— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: 549300CJWLXX2MXVVV71
SEC EDGAR CIK: 0001285819
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2026-03-31
Omeros Corporation (biotechnology/pharmaceuticals) discloses in 10-K Item 1C that it maintains a cybersecurity risk management program, including technical, physical, and organizational measures, third-party vendor risk assessments, and employee training (including simulated phishing). The company explicitly states it is not aware of any specific cybersecurity threats that have materially affected or are reasonably likely to materially affect its business, strategy, results of operations, or financial condition. No specific incidents, data breaches, or material impacts are reported.